Category Archives: Congenital disorders

Global Patient Handling Equipment Market Size To Grow USD 18.9 Billion By 2032

New York, United States, Nov. 14, 2023 (GLOBE NEWSWIRE) — Global Patient Handling Equipment Market Size is To Grow from USD 10.4 Billion in 2022 to USD 18.9 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.                          […]

Global Opioid Use Disorder (OUD) Market Size To Grow USD 7.8 Billion by 2032

New York, United States, Nov. 14, 2023 (GLOBE NEWSWIRE) — The Global Opioid Use Disorder (OUD) Market Size is To Grow from USD 2.8 Billion in 2022 to USD 7.8 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period. Get a Sample PDF Brochure https://www.sphericalinsights.com/request-sample/2364   Opioids are synthesized in […]

Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial

Study design and overview This study employed a randomized controlled trial design. It was conducted at the Infertility and Reproductive Biology Unit of the Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, from November 2020 to December 2021. Eligible participants were randomly allocated to a “combination group” or a […]

FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic Purpura

MONDAY, Nov. 13, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Adzynma, the first recombinant protein product indicated for prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP). Adzynma is a purified recombinant form of the ADAMTS13 enzyme that enhances the low […]

Upcoming Phase 3 Trials to Evaluate Efficacy, Safety of Milvexian in Patients with Cardiovascular Conditions

In an interview with Pharmacy Times, former American Heart Association president Robert Harrington, MD, professor of medicine at Stanford University, phase 3 program chair, cardiologist, dean of Weill Cornell Medicine, and provost for medical affairs at Cornell University, discussed the Librexia program and how it aims to enhance the benefit-risk profile in patients with cardiovascular […]

Assessment of Perceptions & Predictors towards Consanguinity

Introduction Consanguinity refers to the relationship between any two individuals who are biologically related. In clinical genetics, consanguinity is defined as the marriage between two individuals who are related as second cousins or closer (ie, Inbreeding coefficient ≥0.0156).1 Consanguinity is estimated using inbreeding coefficient, which is a genetic measure of how two people are closely […]

New VP&S Faculty

The VP&S Office of Faculty Affairs has provided this list of full-time faculty who joined the medical school in August 2023.  Amit Batta, DO, Psychiatry Jehanne Belange, MD, Emergency Medicine Tom D. Ben Dov, MD, Otolaryngology/Head & Neck Surgery: Ben Dov has joined the Division of Pediatric Otolaryngology. His research interests focus on the genomics […]

Adzynma Approved for Congenital Thrombotic Thrombocytopenic Purpura

The Food and Drug Administration (FDA) has approved Adzynma for prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura. Congenital thrombotic thrombocytopenic purpura (cTTP) results from a deficiency in  ADAMTS13 (A disintegrin and metalloproteinase with thrombospondin motifs 13), a von Willebrand factor (VWF) cleaving protease. This leads […]

Intersex Russians fear fallout from curbs on gender-affirming care

Born intersex and raised as a boy, Polina has known for years that she wanted to live as a woman. But Russia’s sweeping curbs on gender-affirming healthcare have made that much more difficult. The 33-year-old from Moscow said that since a new law – which targets transgender people – was passed in July, doctors had […]

UCI researchers discover gene critical for muscle repair

University of California, Irvine researchers have identified a gene expressed during regeneration that is critical for muscle repair. The key human skeletal muscle gene was also found in a subset of muscle fibers that were able to support human muscle stem cells after transplantation. Although skeletal muscle is one of the most regenerative organ systems, […]